EUVIMEDEUVIMED entdecken
Crossref

Bioaccumulation and DNA Adduct Formation of Aristolactam I: Unmasking a Toxicological Mechanism in the Pathophysiology of Aristolochic Acid Nephropathy

Chun-Kit Au iD, Yat-Hing Ham, Wan Chan iD

Chemical Research in Toxicology · 2023

DOI: 10.1021/acs.chemrestox.2c00415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2023. Verfasst von Chun-Kit Au und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong. Hauptthemen laut MEDLINE: Aristolochic Acids, Kidney Diseases, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Research Grants Council, University Grants Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolonged exposure to aristolochic acid (AA) through AA-containing herbal medicines or AA-tainted food is putting a large portion of the global population at risk of developing renal fibrosis and tumors of the upper urinary tract. In an effort to better understand the organotropic property of AA, we studied the cytotoxicity, absorption, oxidative-stress inducing potential, and DNA adduct formation capability of aristolactam I (ALI), one of the major urinary metabolites of aristolochic acid I (AAI) in human cells. Despite ALI having a slightly lower cytotoxicity than that of AAI, the analysis revealed, for the first time, that ALI is bioaccumulated 900 times more than that of AAI inside cultured kidney cells. Furthermore, ALI induced a significantly larger glutathione depletion than that of AAI in the exposed cells. Together with the formation of ALI-DNA adduct at a reasonably high abundance, results of this study unmasked a previously disregarded causative role of ALI in the organotropic tumor-targeting property of AA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aristolochic AcidsKidney DiseasesNeoplasmsHumansDNA AdductsBioaccumulationCarcinogens

Substanzen

aristolochic acid Iaristolactam IDNA AdductsAristolochic AcidsCarcinogens

Autor:innen und Institutionen

  • Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong.

ORCID-Profile: Chun-Kit Au, Wan Chan

Förderung

  • Research Grants Council, University Grants Committee

Zitieren

APA

Au, C. K., Ham, Y. H., & Chan, W. (2023). Bioaccumulation and DNA Adduct Formation of Aristolactam I: Unmasking a Toxicological Mechanism in the Pathophysiology of Aristolochic Acid Nephropathy. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.2c00415

Vancouver

Au CK, Ham YH, Chan W. Bioaccumulation and DNA Adduct Formation of Aristolactam I: Unmasking a Toxicological Mechanism in the Pathophysiology of Aristolochic Acid Nephropathy. Chemical Research in Toxicology. 2023. doi:10.1021/acs.chemrestox.2c00415

BibTeX
@article{Au2023,
  author = {Au, Chun-Kit and Ham, Yat-Hing and Chan, Wan},
  title = {Bioaccumulation and DNA Adduct Formation of Aristolactam I: Unmasking a Toxicological Mechanism in the Pathophysiology of Aristolochic Acid Nephropathy},
  journal = {Chemical Research in Toxicology},
  year = {2023},
  doi = {10.1021/acs.chemrestox.2c00415}
}
Kostenlos starten →